These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 37573339)

  • 1. PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer's Disease With machine learning: the PREVIEW study protocol.
    Mazzeo S; Lassi M; Padiglioni S; Vergani AA; Moschini V; Scarpino M; Giacomucci G; Burali R; Morinelli C; Fabbiani C; Galdo G; Amato LG; Bagnoli S; Emiliani F; Ingannato A; Nacmias B; Sorbi S; Grippo A; Mazzoni A; Bessi V
    BMC Neurol; 2023 Aug; 23(1):300. PubMed ID: 37573339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of abnormal Alzheimer's disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples.
    Wolfsgruber S; Molinuevo JL; Wagner M; Teunissen CE; Rami L; Coll-Padrós N; Bouwman FH; Slot RER; Wesselman LMP; Peters O; Luther K; Buerger K; Priller J; Laske C; Teipel S; Spottke A; Heneka MT; Düzel E; Drzezga A; Wiltfang J; Sikkes SAM; van der Flier WM; Jessen F;
    Alzheimers Res Ther; 2019 Jan; 11(1):8. PubMed ID: 30654834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TAS Test project: a prospective longitudinal validation of new online motor-cognitive tests to detect preclinical Alzheimer's disease and estimate 5-year risks of cognitive decline and dementia.
    Alty J; Bai Q; Li R; Lawler K; St George RJ; Hill E; Bindoff A; Garg S; Wang X; Huang G; Zhang K; Rudd KD; Bartlett L; Goldberg LR; Collins JM; Hinder MR; Naismith SL; Hogg DC; King AE; Vickers JC
    BMC Neurol; 2022 Jul; 22(1):266. PubMed ID: 35850660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.
    Bessi V; Mazzeo S; Padiglioni S; Piccini C; Nacmias B; Sorbi S; Bracco L
    J Alzheimers Dis; 2018; 63(4):1523-1535. PubMed ID: 29782316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of Alzheimer's Disease and Cerebrovascular Disease in Relation to Depressive Symptomatology in Individuals With Subjective Cognitive Decline.
    Zapater-Fajarí M; Diaz-Galvan P; Cedres N; Rydberg Sterner T; Rydén L; Sacuiu S; Waern M; Zettergren A; Zetterberg H; Blennow K; Kern S; Hidalgo V; Salvador A; Westman E; Skoog I; Ferreira D
    J Gerontol A Biol Sci Med Sci; 2024 Feb; 79(2):. PubMed ID: 37708068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Subjective Cognitive Decline with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    Wen C; Bi YL; Hu H; Huang SY; Ma YH; Hu HY; Tan L; Yu JT
    J Alzheimers Dis; 2022; 85(3):1143-1151. PubMed ID: 34924386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau levels are higher in objective subtle cognitive decline but not subjective memory complaint.
    Thomas KR; Weigand AJ; Edwards LC; Edmonds EC; Bangen KJ; Ortiz G; Walker KS; Bondi MW;
    Alzheimers Res Ther; 2022 Aug; 14(1):114. PubMed ID: 35996158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer's disease in individuals with subjective cognitive decline.
    Pascual-Lucas M; Allué JA; Sarasa L; Fandos N; Castillo S; Terencio J; Sarasa M; Tartari JP; Sanabria Á; Tárraga L; Ruíz A; Marquié M; Seo SW; Jang H; Boada M;
    Alzheimers Res Ther; 2023 Jan; 15(1):2. PubMed ID: 36604729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study.
    Miebach L; Wolfsgruber S; Polcher A; Peters O; Menne F; Luther K; Incesoy E; Priller J; Spruth E; Altenstein S; Buerger K; Catak C; Janowitz D; Perneczky R; Utecht J; Laske C; Buchmann M; Schneider A; Fliessbach K; Kalbhen P; Heneka MT; Brosseron F; Spottke A; Roy N; Teipel SJ; Kilimann I; Wiltfang J; Bartels C; Düzel E; Dobisch L; Metzger C; Meiberth D; Ramirez A; Jessen F; Wagner M
    Alzheimers Res Ther; 2019 Jul; 11(1):66. PubMed ID: 31366409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a smartphone screening test for preclinical Alzheimer's disease and validation across the dementia continuum.
    Alty J; Goldberg LR; Roccati E; Lawler K; Bai Q; Huang G; Bindoff AD; Li R; Wang X; St George RJ; Rudd K; Bartlett L; Collins JM; Aiyede M; Fernando N; Bhagwat A; Giffard J; Salmon K; McDonald S; King AE; Vickers JC
    BMC Neurol; 2024 Apr; 24(1):127. PubMed ID: 38627686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of Alzheimer's Disease and Cerebrovascular Lesions and Clinical Progression in Patients with Subjective Cognitive Decline: A Systematic Review.
    Scarth M; Rissanen I; Scholten RJPM; Geerlings MI
    J Alzheimers Dis; 2021; 83(3):1089-1111. PubMed ID: 34397412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subjective Spatial Navigation Complaints - A Frequent Symptom Reported by Patients with Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease.
    Cerman J; Andel R; Laczo J; Vyhnalek M; Nedelska Z; Mokrisova I; Sheardova K; Hort J
    Curr Alzheimer Res; 2018; 15(3):219-228. PubMed ID: 29165083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the effectiveness of subjective cognitive decline plus criteria in predicting the progression to Alzheimer's disease: an 11-year follow-up study.
    Mazzeo S; Padiglioni S; Bagnoli S; Carraro M; Piaceri I; Bracco L; Nacmias B; Sorbi S; Bessi V
    Eur J Neurol; 2020 May; 27(5):894-899. PubMed ID: 32043740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning-based classification of Alzheimer's disease and its at-risk states using personality traits, anxiety, and depression.
    Waschkies KF; Soch J; Darna M; Richter A; Altenstein S; Beyle A; Brosseron F; Buchholz F; Butryn M; Dobisch L; Ewers M; Fliessbach K; Gabelin T; Glanz W; Goerss D; Gref D; Janowitz D; Kilimann I; Lohse A; Munk MH; Rauchmann BS; Rostamzadeh A; Roy N; Spruth EJ; Dechent P; Heneka MT; Hetzer S; Ramirez A; Scheffler K; Buerger K; Laske C; Perneczky R; Peters O; Priller J; Schneider A; Spottke A; Teipel S; Düzel E; Jessen F; Wiltfang J; Schott BH; Kizilirmak JM
    Int J Geriatr Psychiatry; 2023 Oct; 38(10):e6007. PubMed ID: 37800601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia.
    Mazzeo S; Santangelo R; Bernasconi MP; Cecchetti G; Fiorino A; Pinto P; Passerini G; Falautano M; Comi G; Magnani G
    J Alzheimers Dis; 2016 Oct; 54(4):1495-1508. PubMed ID: 27589522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD.
    Chipi E; Bellomo G; Salvadori N; Montanucci C; Gaetani L; Paolini Paoletti F; Parnetti L
    J Prev Alzheimers Dis; 2023; 10(3):523-529. PubMed ID: 37357293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-Cultural Longitudinal Study on Cognitive Decline (CLoCODE) for Subjective Cognitive Decline in China and Germany: A Protocol for Study Design.
    Sheng C; Yang K; He B; Li T; Wang X; Du W; Hu X; Jiang J; Jiang X; Jessen F; Han Y
    J Alzheimers Dis; 2022; 87(3):1319-1333. PubMed ID: 35431240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.